Get started
ABBOTT LABORATORIESABBOTT LABORATORIESABBOTT LABORATORIES

ABBOTT LABORATORIES

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

ABL chart

Key stats

Market capitalization
‪174.45 B‬EUR
Dividend yield (indicated)
2.05%
Price to earnings Ratio (TTM)
33.36
Basic EPS (TTM)
—
Net income
‪5.17 B‬EUR
Revenue
‪36.34 B‬EUR
Shares float
‪1.72 B‬
Beta (1Y)
0.59

About ABBOTT LABORATORIES

Sector
Health Technology
Industry
Medical Specialties
CEO
Robert B. Ford
Website
abbott.com
Headquarters
Abbott Park
Employees (FY)
‪114 K‬
Founded
1888
FIGI
BBG000H2RGK9
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Sparks

Curated watchlists where ABL is featured.

See all sparks 

Frequently Asked Questions

The current price of ABL is 99.56 EUR — it has decreased by 0.99% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on XETR exchange ABBOTT LABORATORIES stocks are traded under the ticker ABL.
ABBOTT LABORATORIES is going to release the next earnings report on Jul 18, 2024. Keep track of upcoming events with our Earnings Calendar.
ABL stock is 1.82% volatile and has beta coefficient of 0.59. Check out the list of the most volatile stocks — is ABBOTT LABORATORIES there?
ABL earnings for the last quarter are 1.08 EUR per share, whereas the estimation was 1.08 EUR resulting in a 0.04% surprise. The estimated earnings for the next quarter are 0.89 EUR per share. See more details about ABBOTT LABORATORIES earnings.
ABBOTT LABORATORIES revenue for the last quarter amounts to ‪9.28 B‬ EUR despite the estimated figure of ‪9.23 B‬ EUR. In the next quarter revenue is expected to reach ‪9.16 B‬ EUR.
Yes, you can track ABBOTT LABORATORIES financials in yearly and quarterly reports right on TradingView.
ABL stock has fallen by 3.23% compared to the previous week, the month change is a 3.02% fall, over the last year ABBOTT LABORATORIES has showed a 0.56% increase.
ABL net income for the last quarter is ‪1.14 B‬ EUR, while the quarter before that showed ‪1.44 B‬ EUR of net income which accounts for −21.09% change. Track more ABBOTT LABORATORIES financial stats to get the full picture.
Today ABBOTT LABORATORIES has the market capitalization of ‪174.42 B‬, it has decreased by 2.26% over the last week.
Yes, ABL dividends are paid quarterly. The last dividend per share was 0.52 EUR. As of today, Dividend Yield (TTM)% is 1.93%. Tracking ABBOTT LABORATORIES dividends might help you take more informed decisions.
ABBOTT LABORATORIES dividend yield was 1.89% in 2023, and payout ratio reached 63.81%. The year before the numbers were 1.75% and 49.05% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, ABL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABBOTT LABORATORIES stock right from TradingView charts — choose your broker and connect to your account.
ABL reached its all-time high on Dec 30, 2021 with the price of 126.56 EUR, and its all-time low was 13.68 EUR and was reached on Jul 24, 2002.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has ‪114.00 K‬ employees. See our rating of the largest employees — is ABBOTT LABORATORIES on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ABBOTT LABORATORIES technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ABBOTT LABORATORIES stock shows the buy signal. See more of ABBOTT LABORATORIES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ABBOTT LABORATORIES future price: according to them, ABL price has a max estimate of 134.24 EUR and a min estimate of 100.44 EUR. Read a more detailed ABBOTT LABORATORIES forecast: see what analysts think of ABBOTT LABORATORIES and suggest that you do with its stocks.